Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Hairless protein is crucial for healthy skin and hair, and its malfunction can cause hair loss.

Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.